Related Documents
-
Notice: Meetings: Cardiovascular and Renal Drugs Advisory Committee
62 reads -
Notice: Agency information collection activities; proposals, submissions, and approvals
34 reads -
Notice: Meetings: Medical Devices Advisory Committee
97 reads -
Notice: Meetings: Antiviral Drugs Advisory Committee
49 reads -
Notice: Meetings: Medical Devices Advisory Committee
38 reads -
Notice: Meetings: Cellular, Tissue and Gene Therapies Advisory Committee
97 reads -
Notice: Meetings: Medical Devices Advisory Committee
52 reads -
Notice: Meetings:
21 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— Cardiovascular and Renal Drugs Advisory Committee
88 reads -
Notice: Meetings: Medical Devices Advisory Committee
39 reads -
Notice: Medical devices:
Patent extension; regulatory review period determinations— Arthritis Advisory Committee
39 reads -
Notice: Federal Food, Drug, and Cosmetic Act: Psychopharmacologic Drugs Advisory Committee
194 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— Pharmaceutical Science and Clinical Pharmacology Advisory Committee
37 reads -
Notice: Meetings: Antiviral Drugs Advisory Committee
45 reads -
Notice: Meetings: Blood Products Advisory Committee
21 reads -
Notice: Organization, functions, and authority delegations: Division of Blood Disorders
35 reads -
Notice: Federal Food, Drug, and Cosmetic Act: Pediatric Advisory Committee
194 reads -
Notice: Food for human consumption:
Food labeling— Oncological Drugs Advisory Committee
39 reads -
Notice: Medical devices:
Patent extension; regulatory review period determinations— Endocrinologic and Metabolic Drugs Advisory Committee
69 reads -
Notice: Committees; establishment, renewal, termination, etc.: CollaGenex Pharmaceuticals, Inc., approval withdrawn
71 reads
Related Documents
Flag this document
1 Page
